SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
suo
Lv4
415 积分
2021-03-16 加入
最近求助
最近应助
互助留言
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
19天前
已完结
Clinical characteristics and treatment outcome in a large multicentre observational cohort of PDGFRA exon 18 mutated gastrointestinal stromal tumour patients
20天前
已完结
Unraveling the Significance of MET Focal Amplification in Lung Cancer: Integrative NGS, FISH, and IHC Investigation
2个月前
已完结
Preliminary interim data of elzovantinib (TPX-0022), a novel inhibitor of MET/SRC/CSF1R, in patients with advanced solid tumors harboring genetic alterations in MET: Update from the Phase 1 SHIELD-1 trial
2个月前
已完结
Scrambling the genome in cancer: causes and consequences of complex chromosome rearrangements
3个月前
已完结
Effects of aneuploidy on cell behaviour and function
3个月前
已完结
Aneuploidy and complex genomic rearrangements in cancer evolution
3个月前
已完结
Prognostic significance of centromere 17 copy number gain in breast cancer depends on breast cancer subtype
3个月前
已关闭
A census of amplified and overexpressed human cancer genes
3个月前
已完结
Clinicopathologic Features of Breast Carcinoma With 2018 American Society of Clinical Oncology/College of American Pathologists Fluorescence In Situ Hybridization Group 3 (Human Epidermal Growth Factor Receptor 2 Chromosome 17 Centromere Ratio <2.0 and Average Human Epidermal Growth Factor Receptor 2 Copy Number ≥6.0) Breast Cancers
3个月前
已关闭
没有进行任何应助
不用了【积分已退回】
3个月前
已找到【积分已退回】
3个月前
感谢
6个月前
感谢
8个月前
感谢
10个月前
感谢
10个月前
点赞
10个月前
感谢
10个月前
点赞
11个月前
厉害了!!!
11个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论